Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)

SHE:002589 Revenue

Realcan Pharmaceutical Group had revenue of 1.71B CNY in the quarter ending March 31, 2026, a decrease of -2.80%. This brings the company's revenue in the last twelve months to 7.25B, down -5.94% year-over-year. In the year 2025, Realcan Pharmaceutical Group had annual revenue of 7.30B, down -8.42%.

• Revenue (ttm): 7.25B
• Revenue Growth: -5.94%
• P/S Ratio: 0.59
• Revenue / Employee: 3.01M
• Employees: 2,407
• Market Cap: 4.29B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.30B	-670.67M	-8.42%
Dec 31, 2024	7.97B	-67.84M	-0.84%
Dec 31, 2023	8.03B	-4.28B	-34.74%
Jan 1, 2023	12.31B	-8.75B	-41.54%
Jan 1, 2022	21.06B	-6.17B	-22.67%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error